Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org
NCT ID: NCT00302198
Last Updated: 2010-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15000 participants
OBSERVATIONAL
2006-01-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ALS Research Collaborative
NCT06885918
The National Amyotrophic Lateral Sclerosis Registry
NCT01772602
COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry
NCT04559009
PREVENT ALL ALS Study
NCT06581861
Studies in Amyotrophic Lateral Sclerosis (ALS) and Other Neurodegenerative Motor Neuron Disorders
NCT05474235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The information you provide in the ALS registry will be used to evaluate variations in patient care, adherence to standards of care and also to help foster ALS research. An additional focus of this website will be to educate participating patients and visitors to this site about ongoing ALS research.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ALS Registry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* There are no inclusion and exclusion criteria beyond the fact that a person needs to have ALS in order to enroll.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muscular Dystrophy Association
OTHER
Forbes Norris MDA/ALS Research Center
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert G Miller, MD
Role: PRINCIPAL_INVESTIGATOR
California Pacific Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Forbes Norris MDA/ALS Center
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23.112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.